BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34850395)

  • 21. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of Xpert HPV on Self-collected Vaginal Samples for Cervical Cancer Screening Among Women in South Africa.
    Saidu R; Kuhn L; Tergas A; Boa R; Moodley J; Svanholm-Barrie C; Persing D; Campbell S; Tsai WY; Wright TC; Denny L
    J Low Genit Tract Dis; 2021 Jan; 25(1):15-21. PubMed ID: 33105451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protecting the underscreened women in developed countries: the value of HPV test.
    Ibáñez R; Autonell J; Sardà M; Crespo N; Pique P; Pascual A; Martí C; Fibla M; Gutiérrez C; Lloveras B; Moreno-Crespi J; Torrent A; Baixeras N; Alejo M; Bosch FX; de Sanjosé S
    BMC Cancer; 2014 Aug; 14():574. PubMed ID: 25102758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptability and Concordance of Self- Versus Clinician- Sampling for HPV Testing among Rural South Indian Women.
    Madhivanan P; Nishimura H; Ravi K; Pope B; Coudray M; Arun A; Krupp K; Jayakrishna P; Srinivas V
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):971-976. PubMed ID: 33773563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women.
    Obiri-Yeboah D; Adu-Sarkodie Y; Djigma F; Hayfron-Benjamin A; Abdul L; Simpore J; Mayaud P
    BMC Womens Health; 2017 Sep; 17(1):86. PubMed ID: 28950841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-collected cervicovaginal sampling for site-of-care primary HPV-based cervical cancer screening: a pilot study in a rural underserved Greek population.
    Chatzistamatiou K; Chatzaki Ε; Constantinidis Τ; Nena E; Tsertanidou A; Agorastos T
    J Obstet Gynaecol; 2017 Nov; 37(8):1059-1064. PubMed ID: 28631511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility, validity and acceptability of self-collected samples for human papillomavirus (HPV) testing in rural Malawi.
    Esber A; Norris A; Jumbe E; Kandodo J; Nampandeni P; Reese PC; Turner AN
    Malawi Med J; 2018 Jun; 30(2):61-66. PubMed ID: 30627330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does full HPV genotyping perform similarly well in clinician-collected cervical samples and self-collected vaginal samples when using the CLART HPV4S assay?
    Solnæs JV; Njor SH; Tranberg M
    BMC Womens Health; 2023 Feb; 23(1):78. PubMed ID: 36823528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland.
    Virtanen A; Anttila A; Nieminen P
    BMC Womens Health; 2015 Nov; 15():99. PubMed ID: 26542953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections.
    Jentschke M; Chen K; Arbyn M; Hertel B; Noskowicz M; Soergel P; Hillemanns P
    J Clin Virol; 2016 Sep; 82():46-50. PubMed ID: 27434147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy Demonstration Project in Argentina: a population-based, before-and-after retrospective cohort study.
    Arrossi S; Paolino M; Laudi R; Gago J; Campanera A; Marín O; Falcón C; Serra V; Herrero R; Thouyaret L
    Lancet Glob Health; 2019 Jun; 7(6):e772-e783. PubMed ID: 31097279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches.
    Ivanus U; Jerman T; Fokter AR; Takac I; Prevodnik VK; Marcec M; Gajsek US; Pakiz M; Koren J; Celik SH; Kramberger KG; Klopcic U; Kavalar R; Zatler SS; Kuzmanov BG; Florjancic M; Nolde N; Novakovic S; Poljak M; Zakelj MP
    Radiol Oncol; 2018 Sep; 52(4):399-412. PubMed ID: 30216191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
    Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
    PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.
    Hesselink AT; Berkhof J; van der Salm ML; van Splunter AP; Geelen TH; van Kemenade FJ; Bleeker MG; Heideman DA
    J Clin Microbiol; 2014 Mar; 52(3):890-6. PubMed ID: 24391196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between self sampling and provider collected samples for Human Papillomavirus (HPV) Deoxyribonucleic acid (DNA) testing in a Nigerian facility.
    Ajenifuja OK; Ikeri NZ; Adeteye OV; Banjo AA
    Pan Afr Med J; 2018; 30():110. PubMed ID: 30364362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer.
    Snoek BC; Verlaat W; Babion I; Novianti PW; van de Wiel MA; Wilting SM; van Trommel NE; Bleeker MCG; Massuger LFAG; Melchers WJG; Sie D; Heideman DAM; Snijders PJF; Meijer CJLM; Steenbergen RDM
    Int J Cancer; 2019 Jan; 144(2):372-379. PubMed ID: 30192375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples.
    Martinelli M; Latsuzbaia A; Bonde J; Pedersen H; Iacobone AD; Bottari F; Piana AF; Pietri R; Cocuzza CE; Arbyn M;
    Microbiol Spectr; 2024 Mar; 12(3):e0287223. PubMed ID: 38323823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cervical screening initiative for elderly women in Denmark.
    Skorstengaard M; Viborg PH; Telén Andersen AB; Andersen B; Holten Bennetsen M; Jochumsen KM; Johansen T; Larsen LG; Bruun Laustsen MU; Salmani R; Serizawa R; Waldstrøm M; Lynge E
    Acta Obstet Gynecol Scand; 2023 Jun; 102(6):791-800. PubMed ID: 37113048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.